The result indicated that Sphingosine (d18:1)-1-P can also differentiate AFP-negative HCC from cirrhosis patients, and the R2Y (cum) and Q2 (cum) were 0.568 and 0.464, respectively (Figure 3B). This evidence concerns the gene AFP and hepatocellular carcinoma.